{
  "id": 5514,
  "url": "https://nnemf.org/research/5514-increase-in-blood-levels-of-growth-factors-involved",
  "title": "Increase in Blood Levels of Growth Factors Involved in the Neuroplasticity Process by Using an Extremely Low Frequency Electromagnetic Field in Post-stroke Patients.",
  "authors": [
    "Natalia Cichoń",
    "Michał Bijak",
    "Piotr Czarny",
    "Elżbieta Miller",
    "Ewelina Synowiec",
    "Tomasz Sliwinski",
    "Joanna Saluk-Bijak"
  ],
  "journal": "Frontiers in aging neuroscience",
  "year": "2018",
  "doi": "10.3389/fnagi.2018.00294",
  "pmid": "30319398",
  "abstract": "Neuroplasticity ensures the improvement of functional status in patients after stroke. The aim of this study was to evaluate the effect of extremely low-frequency electromagnetic field therapy (ELF-EMF) on brain plasticity in the rehabilitation of patients after stroke. Forty-eight patients were divided into two groups underwent the same rehabilitation program, but in the study group, the patients additionally were exposed to a standard series of 10 ELF-EMF treatments. To determine the level of neuroplasticity, we measured the plasma level of the brain-derived neurotrophic factor (BDNF), the vascular-endothelial growth factor, as well as BDNF mRNA expression. Additionally, we determined the molecule levels for hepatocyte growth factor, stem cell factor, stromal cell-derived factor 1α, nerve growth factor β, and leukemia inhibitory factor, using 5plex cytokine panel in plasma. After 4 weeks, during which patients had undergone neurorehabilitation and neurological examinations, we assessed functional recovery using the Barthel Index, Mini-Mental State Examination (MMSE), Geriatric Depression Scale, National Institutes of Health Stroke Scale (NIHSS), and the modified Rankin Scale (mRS). We observed that ELF-EMF significantly increased growth factors and cytokine levels involved in neuroplasticity, as well as promoted an enhancement of functional recovery in post-stroke patients. Additionally, we presented evidence that these effects could be related to the increase of gene expression on the mRNA level. Moreover, a change of BDNF plasma level was positively correlated with the Barthel Index, MMSE, and negatively correlated with GDS. Extremely low-frequency electromagnetic field therapy improves the effectiveness of rehabilitation of post-stroke patients by improving neuroplasticity processes.",
  "effect": "benefit",
  "evidence": "low",
  "extraction": {
    "studyType": "other",
    "studyTypeLabel": "Other",
    "effectDirection": "benefit",
    "evidenceLabel": "Low",
    "population": "Post-stroke patients undergoing rehabilitation",
    "sampleSize": "48",
    "exposure": "ELF therapeutic device (ELF-EMF therapy) · standard series of 10 ELF-EMF treatments; outcomes assessed after 4 weeks",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "Compared with rehabilitation alone, adding a standard series of 10 ELF-EMF treatments was reported to significantly increase multiple growth factors/cytokines involved in neuroplasticity and to enhance functional recovery after 4 weeks. Change in plasma BDNF was positively correlated with Barthel Index and MMSE and negatively correlated with GDS; effects were suggested to relate to increased mRNA expression.",
    "outcomes": [
      "Plasma brain-derived neurotrophic factor (BDNF) level",
      "Vascular-endothelial growth factor level",
      "BDNF mRNA expression",
      "Plasma hepatocyte growth factor level",
      "Plasma stem cell factor level",
      "Plasma stromal cell-derived factor 1α level",
      "Plasma nerve growth factor β level",
      "Plasma leukemia inhibitory factor level",
      "Barthel Index",
      "Mini-Mental State Examination (MMSE)",
      "Geriatric Depression Scale (GDS)",
      "National Institutes of Health Stroke Scale (NIHSS)",
      "Modified Rankin Scale (mRS)"
    ],
    "limitations": [
      "Frequency/intensity parameters of ELF-EMF exposure not reported in the abstract",
      "Randomization/blinding and allocation methods not described in the abstract",
      "No quantitative effect sizes or between-group statistics provided in the abstract",
      "Follow-up duration limited to 4 weeks in the abstract"
    ],
    "keywords": [
      "extremely low frequency",
      "ELF-EMF",
      "stroke rehabilitation",
      "neuroplasticity",
      "BDNF",
      "growth factors",
      "cytokines",
      "functional recovery"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"other\",\n  \"exposure\": {\n    \"band\": \"ELF\",\n    \"source\": \"therapeutic device (ELF-EMF therapy)\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": \"standard series of 10 ELF-EMF treatments; outcomes assessed after 4 weeks\"\n  },\n  \"population\": \"Post-stroke patients undergoing rehabilitation\",\n  \"sample_size\": 48,\n  \"outcomes\": [\n    \"Plasma brain-derived neurotrophic factor (BDNF) level\",\n    \"Vascular-endothelial growth factor level\",\n    \"BDNF mRNA expression\",\n    \"Plasma hepatocyte growth factor level\",\n    \"Plasma stem cell factor level\",\n    \"Plasma stromal cell-derived factor 1α level\",\n    \"Plasma nerve growth factor β level\",\n    \"Plasma leukemia inhibitory factor level\",\n    \"Barthel Index\",\n    \"Mini-Mental State Examination (MMSE)\",\n    \"Geriatric Depression Scale (GDS)\",\n    \"National Institutes of Health Stroke Scale (NIHSS)\",\n    \"Modified Rankin Scale (mRS)\"\n  ],\n  \"main_findings\": \"Compared with rehabilitation alone, adding a standard series of 10 ELF-EMF treatments was reported to significantly increase multiple growth factors/cytokines involved in neuroplasticity and to enhance functional recovery after 4 weeks. Change in plasma BDNF was positively correlated with Barthel Index and MMSE and negatively correlated with GDS; effects were suggested to relate to increased mRNA expression.\",\n  \"effect_direction\": \"benefit\",\n  \"limitations\": [\n    \"Frequency/intensity parameters of ELF-EMF exposure not reported in the abstract\",\n    \"Randomization/blinding and allocation methods not described in the abstract\",\n    \"No quantitative effect sizes or between-group statistics provided in the abstract\",\n    \"Follow-up duration limited to 4 weeks in the abstract\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"extremely low frequency\",\n    \"ELF-EMF\",\n    \"stroke rehabilitation\",\n    \"neuroplasticity\",\n    \"BDNF\",\n    \"growth factors\",\n    \"cytokines\",\n    \"functional recovery\"\n  ],\n  \"suggested_hubs\": [\n    {\n      \"slug\": \"rehabilitation-therapeutic-emf\",\n      \"weight\": 0.9,\n      \"reason\": \"Study evaluates ELF-EMF as an adjunct therapy during post-stroke rehabilitation with functional and biomarker outcomes.\"\n    }\n  ]\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/30319398/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=5514",
  "updated": "2026-02-14 08:45:57"
}